According to Precedence Research, the global wearable cardiac devices market size will grow from USD 4.68 billion in 2025 to ...

The market has left medical device stocks in the dust, but heart monitor maker iRhythm Technologies is proving an exception.

Smartwatches have gone from being a technological accessory to becoming a useful health tool. However, you may wonder how ...

In a randomized trial, adding an antiplatelet to anticoagulant therapy in patients with ischemic stroke, nonvalvular atrial fibrillation, and atherosclerosis provided no significant benefit. There was ...

Across studies, the rate of sudden death in ibrutinib-treated patients ranged from 0.49 to 0.788 per 100 patient-years, roughly double that seen in comparators. In contrast, pooled analyses of ...

The Digital Health Hub Foundation 2025 Digital Health Awards recognized OMRON Healthcare as a Best in Class Winner in the Home Health Diagnostics & Monitoring category for its ...

While preparations and collaboration among officials in multiple jurisdictions have been ongoing for months, safety and ...

Atrial fibrillation (AFib) is a cardiac disorder in which the chambers of the heart beat rapidly and irregularly. It's the ...

Expert judges determining the best of the best in healthcare innovation recognized OMRON Healthcare for its blood pressure ...

The global cardiac monitoring and cardiac rhythm management (CRM) devices market is entering a decade of robust expansion, ...

Atrial fibrillation, or A-fib, is the most common type of arrhythmia, affecting at least 2.7 million people in the United States. This number is expected to grow to more than 12 million by 2030, which ...